We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In a collaboration potentially valued at $1.9 billion, Amgen is teaming up with Cambridge, Mass.-based Generate Biomedicines to develop protein therapeutics for up to five clinical targets. Read More
Dr. Reddy’s and Merck previously struck a licensing pact enabling the generics maker to supply molnupiravir to India and more than 100 low- and middle-income nations. Read More
Already, pharmaceutical companies have increased prices for 456 brand name drugs for 2022, with the median increase coming in at a relatively modest 4.9 percent. Read More
The hospitals pointed out that two federal courts have ruled drug companies are violating the law and don’t have the right to unilaterally impose these types of restrictions on 340B discounts. Read More
Novartis announced that it will acquire the UK-based ocular gene therapy company Gyroscope Therapeutics, giving Novartis a one-time gene therapy for geographic atrophy (GA), a leading cause of blindness. Read More
In a purchase aimed at broadening its portfolio of cancer therapies, Sanofi is acquiring San Francisco, Calif.-based Amunix Pharmaceuticals for $1 billion. Read More